Drug programs - modern therapies
Treatment of chronic hepatitis C with interferon-free therapy
Welcome to licensed pharmacies in Poland:
Non-prescription medicines delivery across Europe.
Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.
What should be used after treatment with Epclus 400+100?
What to drink after Epcluse 400+100?
EpclusaHepatologTelekonsultacjeDrug programs - modern therapiesJaundice and viral hepatitis (HEPATITIS)LiverTreatment of chronic hepatitis C with interferon-free therapyWhat harms the liver?
1 answer
* required field
You can drag the photo file here.
* required field
Notify of a new answer.
Other messages will not be sent.
Other messages will not be sent.
Suggested Products
Space for your product
Anna Lewandowska Pharmacist, Editor
3 months ago
After completion of treatment with Epclusa (sofosbuvir + velpatasvir), there is usually no need for additional antiviral medications if treatment has been successfully completed.
However, it is worth supporting the regeneration of the body through a healthy diet, proper hydration and avoiding substances that burden the liver, such as alcohol or certain medications. Sometimes your doctor may recommend liver support supplements, such as B vitamins or phospholipids, but this should always be agreed with your doctor. Regular control of laboratory results will help monitor health after therapy.
If you need more personalized advice, you can use teleconsultations here:
https://www.gdziepolek.pl/telekonsultacja/
The advice is provided in Polish.
The availability of Epclusa in pharmacies in Polish can be checked at the following address:
https://www.gdziepolek.pl/produkty/92786/epclusa-tabletki-powlekane/apteki
Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.